RMH Holdings
Market Cap
HK$84.0m
Last Updated
2020/01/23 13:07 UTC
Data Sources
Company Financials
Executive Summary
RMH Holdings Limited, an investment holding company, provides dermatology treatment solutions in Singapore.
Snowflake Analysis
Flawless balance sheet and good value.
Share Price & News
How has RMH Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 8437's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
-12.0%
8437
-1.9%
HK Healthcare
-1.4%
HK Market
1 Year Return
-53.3%
8437
-18.5%
HK Healthcare
3.5%
HK Market
Return vs Industry: 8437 underperformed the Hong Kong Healthcare industry which returned -12.9% over the past year.
Return vs Market: 8437 underperformed the Hong Kong Market which returned 6.4% over the past year.
Shareholder returns
| 8437 | Industry | Market | |
|---|---|---|---|
| 7 Day | -12.0% | -1.9% | -1.4% |
| 30 Day | -13.0% | 1.8% | 1.8% |
| 90 Day | -33.3% | 1.2% | 6.0% |
| 1 Year | -53.3%-53.3% | -16.7%-18.5% | 7.3%3.5% |
| 3 Year | n/a | -26.0%-30.4% | 23.3%10.8% |
| 5 Year | n/a | -18.0%-25.2% | 19.2%-0.7% |
Price Volatility Vs. Market
How volatile is RMH Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall St
A Sliding Share Price Has Us Looking At RMH Holdings Limited's (HKG:8437) P/E Ratio2 months ago | Simply Wall St
Some RMH Holdings (HKG:8437) Shareholders Have Copped A Big 53% Share Price Drop3 months ago | Simply Wall St
Do Directors Own RMH Holdings Limited (HKG:8437) Shares?Valuation
Is RMH Holdings undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 8437 (HK$0.16) is trading below our estimate of fair value (HK$0.3)
Significantly Below Fair Value: 8437 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 8437 is good value based on its PE Ratio (15.9x) compared to the Healthcare industry average (16.5x).
PE vs Market: 8437 is poor value based on its PE Ratio (18.2x) compared to the Hong Kong market (10.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 8437's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 8437 is good value based on its PB Ratio (1.1x) compared to the HK Healthcare industry average (1.4x).
Next Steps
Future Growth
How is RMH Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
19.3%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RMH Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine whether RMH Holdings is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- RMH Holdings competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has RMH Holdings performed over the past 5 years?
-24.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 8437 has high quality earnings.
Growing Profit Margin: 8437's current net profit margins (13.1%) are higher than last year (10.4%).
Past Earnings Growth Analysis
Earnings Trend: 8437's earnings have declined by -24% per year over the past 5 years.
Accelerating Growth: 8437's earnings growth over the past year (20.6%) exceeds its 5-year average (-24% per year).
Earnings vs Industry: 8437 earnings growth over the past year (20.6%) exceeded the Healthcare industry 10.4%.
Return on Equity
High ROE: 8437's Return on Equity (6.1%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is RMH Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 8437's short term assets (SGD14.1M) exceed its short term liabilities (SGD1.7M).
Long Term Liabilities: 8437's short term assets (SGD14.1M) exceed its long term liabilities (SGD871.0K).
Debt to Equity History and Analysis
Debt Level: 8437 is debt free.
Reducing Debt: 8437 had no debt 5 years ago.
Debt Coverage: 8437 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 8437 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: 8437 has a low level of unsold assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if 8437's debt is covered by short term assets.
Next Steps
Dividend
What is RMH Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate 8437's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate 8437's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 8437's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 8437's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 8437's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
What is the CEO of RMH Holdings's salary, the management and board of directors tenure and is there insider trading?
2.7yrs
Average management tenure
CEO
Raymond Kwah (43yo)
2.7yrs
Tenure
S$312,000
Compensation
Dr. Kwah Yung Chien, also known as Raymond, has been the Chief Executive Officer and Executive Director of RMH Holdings Limited since May 18, 2017 and March 22, 2017 respectively. Dr. Kwah is responsible f ...
CEO Compensation Analysis
Compensation vs Market: Raymond's total compensation ($USD231.64K) is about average for companies of similar size in the Hong Kong market ($USD228.16K).
Compensation vs Earnings: Raymond's compensation has been consistent with company performance over the past year.
Management Age and Tenure
2.7yrs
Average Tenure
42yo
Average Age
Experienced Management: 8437's management team is considered experienced (2.7 years average tenure).
Board Age and Tenure
2.5yrs
Average Tenure
44.5yo
Average Age
Experienced Board: 8437's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Management Team
Yun Wah Man (36yo)
Company Secretary
- Tenure: 2.7yrs
Teck Hiong Loh (49yo)
Chairman & Compliance Officer
- Tenure: 2.7yrs
- Compensation: S$312.00k
Hock Leong Ee (46yo)
Executive Director
- Tenure: 2.8yrs
- Compensation: S$312.00k
Raymond Kwah (43yo)
CEO & Executive Director
- Tenure: 2.7yrs
- Compensation: S$312.00k
Sun Yangling Swee (41yo)
Operations Manager
Shally Ang (28yo)
Chief Financial Officer
- Tenure: 1yrs
Board Members
Vincent Cheung (43yo)
Independent Non Executive Director
- Tenure: 2.3yrs
- Compensation: S$21.00k
Joshua Ong (51yo)
Independent Non Executive Director
- Tenure: 2.3yrs
- Compensation: S$31.00k
Teck Hiong Loh (49yo)
Chairman & Compliance Officer
- Tenure: 2.7yrs
- Compensation: S$312.00k
Hock Leong Ee (46yo)
Executive Director
- Tenure: 2.8yrs
- Compensation: S$312.00k
Raymond Kwah (43yo)
CEO & Executive Director
- Tenure: 2.7yrs
- Compensation: S$312.00k
Ning Wang (41yo)
Independent Non-Executive Director
- Tenure: 1.6yrs
- Compensation: S$12.00k
Company Information
RMH Holdings Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: RMH Holdings Limited
- Ticker: 8437
- Exchange: SEHK
- Founded: 2017
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: HK$84.000m
- Shares outstanding: 600.00m
- Website: https://www.rmhholdings.com.sg
Number of Employees
Location
- RMH Holdings Limited
- No 15-09 Paragon (Office Tower)
- 290 Orchard Road
- Singapore
- 238859
- Singapore
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 8437 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Oct 2017 |
Biography
RMH Holdings Limited, an investment holding company, provides dermatology treatment solutions in Singapore. It offers specialty care services for various dermatological conditions affecting skin, hair, and nails through medical, surgical, laser, and aesthetic treatments. The company also provides consultancy, prescription and dispensing, and treatment services. It offers treatment of skin cancer; and skin diseases, such as eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts. The company operates three clinics at Orchard Road, Raffles Place, and East Coast. The company was incorporated in 2017 and is headquartered in Singapore. RMH Holdings Limited is a subsidiary of Brisk Success Holdings Limited.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/01/23 13:07 |
| End of Day Share Price | 2020/01/22 00:00 |
| Earnings | 2019/09/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.